|Print This Page Email to a Friend|
Antoinette R. Tan, MD, MHSc
Antoinette R. Tan, MD, MHSc, recently joined Carolinas HealthCare System’s Levine Cancer Institute to serve as the chief of breast medical oncology and co-director of the Phase I Program, which is focused on bringing cancer patients novel experimental drugs through enrolling them in clinical trials. In her role, Dr. Tan will also serve as chief of breast medical oncology at Carolinas Medical Center-Pineville. Dr. Tan joins the Institute’s multidisciplinary team of breast cancer providers, including highly specialized and trained physicians, nurse navigators, social workers and dietitians.
Dr. Tan’s expertise in treating patients with breast cancer, as well as conducting high quality research with novel, targeted therapies, will offer substantial benefit for our patients at multiple locations throughout North and South Carolina,” said Edward S. Kim, MD, chair of solid tumor oncology and investigational therapeutics at the Institute. “We are fortunate to have her join our staff of nationally recognized physicians, and I am excited for the continued development of our comprehensive, multidisciplinary breast cancer program, as well as our early phase therapeutics program.”
Dr. Tan comes to the Institute from Rutgers Cancer Institute of New Jersey, where she served as director of Phase I and investigational therapeutics and associate professor of medicine. Her research is focused on the development of novel therapeutics for breast cancer, and she has plans to open several new clinical trials at the Institute to test promising new classes of drugs.
Learn more about 22-year old Jessie Miller’s journey with breast cancer, and the support she received from physicians and staff at Levine Cancer Institute every step of the way.